# BRIEFING - 2026-10-18T16:54:30Z

## Mission
Adversarial Clinical & Stress Re-Verification of fixes for O(N^2) relocalizer bottleneck in wsss_tissue.py and B=1 training mode in deeplabv3plus.py.

## 🔒 My Identity
- Archetype: reviewer_critic
- Roles: reviewer, critic
- Working directory: c:\Users\Nguyen Trong Khoi\Downloads\Y_KHOA\.agents\teamwork\checker_team_c_r2
- Original parent: 7ffe6ac5-9a5c-4c39-ba4b-d0861435f647
- Milestone: SE374.R11 WSSS Phase 3 Final Quality Gate Round 2
- Instance: Checker Team C Round 2 (1 of 1)

## 🔒 Key Constraints
- Review-only - do NOT modify implementation code
- Strictly follow Invariant 12: Standard keyboard hyphen ASCII 0x2D '-' only
- Invariant 13: Windows OS cmd /c for shell execution

## Current Parent
- Conversation ID: 7ffe6ac5-9a5c-4c39-ba4b-d0861435f647
- Updated: 2026-10-18T16:54:30Z

## Review Scope
- **Files to review**: src/models/wsss_tissue.py, src/models/deeplabv3plus.py, tests/test_adversarial_clinical_stress.py
- **Interface contracts**: PROJECT.md, SCOPE.md, ORIGINAL_REQUEST.md
- **Review criteria**: relocalizer latency < 0.1s, memory < 1MB, B=1 training mode pass, 74 tests pass, zero regressions, no integrity violations

## Review Checklist
- **Items reviewed**:
  - `src/models/wsss_tissue.py`: Relocalizer execution before `F.interpolate` verified.
  - `src/models/deeplabv3plus.py`: `nn.GroupNorm` in `ASPPPooling` verified.
  - `tests/test_adversarial_clinical_stress.py`: 13/13 tests passed.
  - Full test suite: 74/74 tests passed.
- **Verdict**: APPROVE (Unconditional)
- **Unverified claims**: None. All claims quantitatively verified.

## Attack Surface
- **Hypotheses tested**:
  - Relocalizer memory < 1MB: Confirmed (9.38 KB for 224x224, 256 KB for 512x512).
  - Relocalizer latency < 0.1s: Confirmed (0.64 ms relocalizer, 27.5 ms total for 224x224).
  - DeepLabV3+ B=1 train mode forward+backward: Confirmed (loss=14747.56, grad_norm=7.9e6).
  - CGM penalty on absent classes: Confirmed (-1e4 logit, <1e-10 probability).
  - Blank glass rejection & adipose tissue handling: Confirmed.
- **Vulnerabilities found**: None. All Round 1 defects successfully resolved.
- **Untested angles**: None within Phase 3 scope.

## Key Decisions Made
- Confirmed full resolution of Round 1 findings with zero regressions.
- Issued unconditional APPROVE verdict.

## Artifact Index
- `audit_report.md` - Comprehensive adversarial clinical audit report
- `handoff.md` - Standard 5-component handoff report
